Eveline Weerdenburg

Dr. Eveline Weerdenburg

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2022 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
TMTetsuya Matsumoto
Tetsuya Matsumoto
HMHiroshige Mikamo
Hiroshige Mikamo
HOHiroki Ohge
Hiroki Ohge
KYKatsunori Yanagihara
Katsunori Yanagihara
EWEveline Weerdenburg
Eveline Weerdenburg
MKMitsuo Kaku
Mitsuo Kaku

31 December 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
EWEveline Weerdenburg
Eveline Weerdenburg
SKSusan King
Susan King
JLJoyce Lübbers
Joyce Lübbers
EHElise Hovingh
Elise Hovingh
TDTodd Davies
Todd Davies
JPJan Poolman
Jan Poolman
Extraintestinal pathogenic Escherichia coli (ExPEC) is a major cause of infections of the urinary tract, the bloodstream, and other non-intestinal sites in humans. ExPEC often resists the bactericidal action of human immune defenses including complement, antimicrobial peptides, antibodies, and cell-mediated killing. This review provides an overview of the main host defense strategies, and the mechanisms and molecules ExPEC engages to resist these human immune responses. Surface-exposed polysaccharides, outer membrane proteins, cytotoxins, and proteases are all part of the bacterial arsenal of defenses that can neutralize many of the host’s immune defenses. These factors work in concert to enable ExPEC to survive and thrive in extraintestinal environments of the human body.